Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T20:35:52.826Z.
Calculation as of: 2026-10-06T20:35:52.826Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5c882cca81b2c0fe2c09916b57b0a50c93804d18514abf2397940823ad07c5bd
EARNINGS YIELD
N/A
CAMP4 Therapeutics Corporation
Market Cap
$248.50M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$247.62M
Earnings Yield
N/A
TTM Avg
37.01%
3Y Avg
37.01%
5Y Avg
37.01%
Market Cap
$247.27M
Earnings Yield
N/A
TTM Avg
3.91%
3Y Avg
3.79%
5Y Avg
2.20%
Market Cap
$241.94M
Earnings Yield
N/A
TTM Avg
2.23%
3Y Avg
2.23%
5Y Avg
2.23%
Market Cap
$255.88M
Earnings Yield
N/A
TTM Avg
1.20%
3Y Avg
4.13%
5Y Avg
3.97%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CAMP4 Therapeutics Corporation (CAMP) | $248.50M | N/A | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $247.62M | N/A | 37.01% | 37.01% | 37.01% |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $247.27M | N/A | 3.91% | 3.79% | 2.20% |
| Upstream Bio, Inc. (UPB)vs › | $249.79M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | N/A | 2.23% | 2.23% | 2.23% |
| Q32 Bio Inc. (QTTB)vs › | $241.39M | 34.40% | 26.39% | 26.39% | 30.90% |
| Quantum-Si incorporated (QSI)vs › | $241.34M | N/A | N/A | N/A | N/A |
| Anika Therapeutics, Inc. (ANIK)vs › | $255.88M | N/A | 1.20% | 4.13% | 3.97% |
| AC Immune S.A. (ACIU)vs › | $256.47M | N/A | 8.07% | 8.07% | 7.35% |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
